AZYO insider filings
AZIYO BIOLOGICS, INC. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-23. Screen AZYO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AZYO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AZIYO BIOLOGICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-23 | 4 | Mills C Randal — PRESIDENT AND CEO, Director | Option exercise (M): 22,474 · Tax withholding (F): 7,772 @ $2.41 · Option exercise (M): 22,474 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Colpman David — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Jordan Maybelle — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Makes Brigid — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — Director, 10% owner HIGHCAPE PARTNERS QP, L.P. — Director, 10% owner HighCape Partners GP, LLC — Director, 10% owner HighCape Partners GP, L.P. — Director, 10% owner HighCape Co-Investment Vehicle I, LLC — Director, 10% owner HighCape Co-Investment Vehicle II, LLC — Director, 10% owner HighCape Capital, LLC — Director, 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | Mills C Randal — PRESIDENT AND CEO, Director | Option exercise (M): 44,947 @ $0 · Grant/award (A): 134,840 (derivative) @ $0 · Option exercise (M): 44,947 (derivative) @ $0 · Grant/award (A): 89,894 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Birchview Capital, LP — 10% owner Birchview Fund LLC — 10% owner Strobeck Matthew — 10% owner | Purchase (P): 100,000 @ $1.49 · Purchase (P): 10,000 @ $1.49 · Purchase (P): 18,000 @ $1.35 · Purchase (P): 2,000 @ $1.35 · Purchase (P): 10,000 @ $1.59 | EDGAR |
| 2023-03-09 | 4 | Englese Thomas — CHIEF COMMERCIAL OFFICER | Option exercise (M): 937 @ $0 · Sale (S): 289 @ $4.30 · Option exercise (M): 937 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Ferguson Matthew — CHIEF FINANCIAL OFFICER | Option exercise (M): 1,287 @ $0 · Option exercise (M): 1,287 (derivative) @ $0 | EDGAR |
| 2023-02-13 | 4 | Birchview Capital, LP — 10% owner Birchview Fund LLC — 10% owner Strobeck Matthew — 10% owner | Purchase (P): 200 @ $5.96 · Purchase (P): 40,000 @ $4.75 · Purchase (P): 10,000 @ $3.58 · Purchase (P): 34,000 @ $3.58 · Purchase (P): 9,061 @ $3.79 · Purchase (P): 4,000 @ $3.79 | EDGAR |
| 2022-12-28 | 4 | HighCape Partners GP II, LLC — 10% owner HighCape Partners GP II, L.P. — 10% owner HighCape Partners QP II, L.P. — 10% owner HighCape Partners II, L.P. — 10% owner | Grant/award (A): 17,533 (derivative) @ $0 | EDGAR |
| 2022-12-27 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — Director, 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Grant/award (A): 17,533 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | Colpman David — Director | Purchase (P): 3,098 @ $3.90 | EDGAR |
| 2022-12-12 | 4 | Makes Brigid — Director | Purchase (P): 2,000 @ $3.65 | EDGAR |
| 2022-12-07 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Purchase (P): 735,000 @ $4.75 | EDGAR |
| 2022-12-05 | 4 | Ferguson Matthew — CHIEF FINANCIAL OFFICER | Purchase (P): 6,000 @ $4.03 · Purchase (P): 20,000 @ $4.75 · Purchase (P): 2,000 @ $3.61 | EDGAR |
| 2022-10-24 | 4 | Colpman David — Director | Grant/award (A): 28,513 (derivative) @ $0 | EDGAR |
| 2022-10-24 | 4 | Williams Michelle LeRoux — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | Englese Thomas — CHIEF COMMERCIAL OFFICER | Option exercise (M): 15,390 · Tax withholding (F): 4,728 @ $7.30 · Option exercise (M): 15,390 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | Riebman Jerome — CHIEF MEDICAL OFFICER | Option exercise (M): 14,758 · Tax withholding (F): 5,104 @ $7.30 · Option exercise (M): 14,758 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | Edwards Peter G — GENERAL COUNSEL | Option exercise (M): 4,625 · Tax withholding (F): 1,127 @ $7.30 · Option exercise (M): 4,625 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | Ferguson Matthew — CHIEF FINANCIAL OFFICER | Option exercise (M): 13,874 · Tax withholding (F): 4,798 @ $7.30 · Option exercise (M): 13,874 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | Mills C Randal — Interim President and CEO, Director | Grant/award (A): 273,767 (derivative) @ $0 · Grant/award (A): 182,511 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Jordan Maybelle — Director | Grant/award (A): 22,090 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Makes Brigid — Director | Grant/award (A): 22,090 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Mills C Randal — Director | Grant/award (A): 22,090 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — Director, 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Grant/award (A): 22,090 (derivative) @ $0 · Grant/award (A): 22,090 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Englese Thomas — CHIEF COMMERCIAL OFFICER | Option exercise (M): 938 @ $0 · Sale (S): 276 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 938 (derivative) @ $0 · Grant/award (A): 15,390 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Roberts Darryl — EVP, OPERATIONS & PRODUCT DEV. | Option exercise (M): 938 @ $0 · Grant/award (A): 37,200 (derivative) @ $0 · Grant/award (A): 10,440 (derivative) @ $0 · Option exercise (M): 938 (derivative) @ $0 · Grant/award (A): 17,024 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Riebman Jerome — CHIEF MEDICAL OFFICER | Option exercise (M): 782 @ $0 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 782 (derivative) @ $0 · Grant/award (A): 14,758 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | LLOYD RONALD K. — PRESIDENT AND CEO, Director | Option exercise (M): 4,072 @ $0 · Grant/award (A): 138,770 (derivative) @ $0 · Grant/award (A): 37,788 (derivative) @ $0 · Option exercise (M): 4,072 (derivative) @ $0 · Grant/award (A): 39,894 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Edwards Peter G — GENERAL COUNSEL | Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Grant/award (A): 4,625 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Ferguson Matthew — CHIEF FINANCIAL OFFICER | Option exercise (M): 1,288 @ $0 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 1,288 (derivative) @ $0 · Grant/award (A): 13,874 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | Englese Thomas — CHIEF COMMERCIAL OFFICER | Purchase (P): 4,580 @ $6.10 | EDGAR |
| 2021-12-10 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Purchase (P): 353,773 @ $4.24 · Purchase (P): 58,962 @ $4.24 | EDGAR |
| 2021-09-01 | 4 | Edwards Peter G — GENERAL COUNSEL | Grant/award (A): 96,200 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Jordan Maybelle — Director | Grant/award (A): 14,082 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Makes Brigid — Director | Grant/award (A): 14,082 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Mills C Randal — Director | Grant/award (A): 14,082 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | HighCape Capital, L.P. — Director, 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — Director, 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Grant/award (A): 14,082 (derivative) @ $0 · Grant/award (A): 14,082 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | Ferguson Matthew — CHIEF FINANCIAL OFFICER | Purchase (P): 1,300 @ $11.14 · Purchase (P): 1,000 @ $11 | EDGAR |
| 2021-05-11 | 4 | LLOYD RONALD K. — PRESIDENT AND CEO, Director | Purchase (P): 7,198 @ $11.65 · Purchase (P): 1,367 @ $12.28 | EDGAR |
| 2020-10-13 | 4 | LLOYD RONALD K. — President and CEO, Director | Conversion (C): 14,586 @ $0 · Conversion (C): 111,788 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | HighCape Capital, L.P. — 10% owner HIGHCAPE PARTNERS, L.P. — 10% owner HIGHCAPE PARTNERS QP, L.P. — 10% owner HighCape Partners GP, LLC — 10% owner HighCape Partners GP, L.P. — 10% owner HighCape Co-Investment Vehicle I, LLC — 10% owner HighCape Co-Investment Vehicle II, LLC — 10% owner HighCape Capital, LLC — 10% owner Zuga Matt — Director, 10% owner RAKIN KEVIN — Director, 10% owner | Conversion (C): 4,062,451 @ $0 · Option exercise/expiry (X): 7,655 @ $5.44 · Tax withholding (F): 2,451 @ $5.44 · Purchase (P): 441,176 @ $17 · Conversion (C): 31,133,977 (derivative) @ $0 · Option exercise/expiry (X): 7,655 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | Riebman Jerome — Chief Medical Officer | Grant/award (A): 30,412 (derivative) @ $0 · Grant/award (A): 10,186 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | Englese Thomas — Chief Commercial Officer | Grant/award (A): 33,488 (derivative) @ $0 · Grant/award (A): 13,890 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | Roberts Darryl — EVP, Operations & Product Deve | Grant/award (A): 50,083 (derivative) @ $0 · Grant/award (A): 11,112 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | LLOYD RONALD K. — President and CEO, Director | Grant/award (A): 181,783 (derivative) @ $0 · Grant/award (A): 100,425 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | Ferguson Matthew — Chief Financial Officer | Grant/award (A): 81,800 (derivative) @ $0 | EDGAR |
Recent 8-K events — AZIYO BIOLOGICS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AZYO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs